KDMF (Korea Drug Master File) Approved Products & Companies

  • Product:

    Naloxone hydrochloride

  • Initial Registration:

    2013-06-14

  • Registration Number:

    20130507-176-I-164-01(1)

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Mundipharma Korea Co., Ltd.

  • Last Modified:

    2025-06-26

  • Country:

    france

  • Status:

    Active

  • Manufacturer:

    Sanofi Winthrop Industrie

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2024

  • Manufacturing Facility:

    Route d'Avignon 30390 Aramon France

  • Product:

    Tramadol hydrochloride

  • Initial Registration:

    2012-09-13

  • Registration Number:

    20120803-161-I-28-02(1)

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Mundipharma Korea Ltd.

  • Last Modified:

    2024-05-09

  • Country:

    Israel

  • Status:

    Active

  • Manufacturer:

    Wavelength Enterprises Ltd.

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2025

  • Manufacturing Facility:

    Neot Hovav Eco-Industrial Park, POB 3593, Be'er Sheva 8413502, Israel

  • Product:

    Amlodipine besylate

  • Initial Registration:

    2011-03-31

  • Registration Number:

    20110331-130-H-141-16

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Myeongmun Bio Co., Ltd.

  • Last Modified:

    2018-09-05

  • Country:

  • Status:

    Active

  • Manufacturer:

    Myeongmun Bio Co., Ltd. @ [Manufacturer of Starting Material (Amlodipine)] Changzhou Ruiming Pharmaceutical Co. Ltd

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2022

  • Manufacturing Facility:

    28, Jeyakgongdan 2-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do (Building 10 and others) @ #1558, Longjiang Bei Road, Chunjiang Town, New-North District, Changzhou, Jiangsu, China

  • Product:

    Acecclofenac

  • Initial Registration:

    2005-09-30

  • Registration Number:

    20050930-31-C-114-11

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Myeongmun Pharmaceutical Co., Ltd.

  • Last Modified:

  • Country:

    china

  • Status:

    Active

  • Manufacturer:

    Zhejiang Yongning Pharmaceutical Factory

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2022

  • Manufacturing Facility:

    No. 4 Meihuajing Lane, Taizhou, Zhejiang, PR China

  • Product:

    Triplelusal

  • Initial Registration:

    2005-08-31

  • Registration Number:

    20050831-66-B-173-05

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Myungin Pharmaceutical Co., Ltd.

  • Last Modified:

    2020-02-12

  • Country:

    Spain

  • Status:

    Active

  • Manufacturer:

    URQUIMA SA

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2023

  • Manufacturing Facility:

    Arnau de vilanova 22-42 08105 Sant fost de Campsentelles (Barcelona), SPAIN

  • Product:

    Sulfasalazine

  • Initial Registration:

    2014-05-09

  • Registration Number:

    20120601-105-F-65-03(1)

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Naeum Pharmaceutical Co., Ltd.

  • Last Modified:

  • Country:

    china

  • Status:

    Active

  • Manufacturer:

    Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd

  • Withdrawal Date:

  • Final Annual Reporting Year:

  • Manufacturing Facility:

    50 Yong Deng Road Shanghai, 200331 PR China

  • Product:

    Flumazenil

  • Initial Registration:

    2016-08-31

  • Registration Number:

    20050831-73-A-142-01(2)

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Narsha Farm Co., Ltd.

  • Last Modified:

    2025-02-14

  • Country:

    Israel

  • Status:

    Active

  • Manufacturer:

    Wavelength Enterprises LTD.

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2024

  • Manufacturing Facility:

    Neot Hovav Eco-Industrial Park, POBox 3593, Be'er Sheva 8413502, Israel

  • Product:

    Apixaban

  • Initial Registration:

    2023-09-20

  • Registration Number:

    Su55-4-ND(3)

  • MFDS Classification:

    new substance

  • Applicant:

    NBP Healthcare Co., Ltd.

  • Last Modified:

  • Country:

    India

  • Status:

    Active

  • Manufacturer:

    Glenmark Life Sciences Limited

  • Withdrawal Date:

  • Final Annual Reporting Year:

  • Manufacturing Facility:

    Plot No 3109, GIDC Industrial Estate, Ankleshwar City: Ankleshwar-393 002, Dist: Bharuch, Gujarat state, India

  • Product:

    Atorvastatin calcium hydrate

  • Initial Registration:

    2023-07-19

  • Registration Number:

    20200318-132-H-354-44(3)

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Neo Co., Ltd.

  • Last Modified:

  • Country:

    India

  • Status:

    Active

  • Manufacturer:

    Hetero Labs Limited (Unit-IX)

  • Withdrawal Date:

  • Final Annual Reporting Year:

  • Manufacturing Facility:

    Plot No.2, Hetero Infrastructure SEZ Ltd., N. Narasapuram Village, Nakkapalli Mandal, Anakapalli District-531 081, Andhra Pradesh, India

  • Product:

    atomoxetine hydrochloride

  • Initial Registration:

    2013-06-18

  • Registration Number:

    Su5702-1-ND

  • MFDS Classification:

    new substance

  • Applicant:

    Neochem Co., Ltd.

  • Last Modified:

  • Country:

    India

  • Status:

    Active

  • Manufacturer:

    Sun Pharmaceutical Industries Limited.

  • Withdrawal Date:

  • Final Annual Reporting Year:

  • Manufacturing Facility:

    Plot No. 24/2, 25, Phase-IV, GIDC Industrial Estate, Panoli-394 116, District Bharuch, Gujarat, India.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.